IngredientsCollagen is a unique, triple-helical molecule that forms the major part of the extracellular matrix. It is the most abundant protein in the human body, representing approximately 30% of its dry weight, and is the fibrous structural protein that makes up the white fibers of skin, tendons, bones, cartilage, and all other connective tissues. The word collagen is derived from the Greek kolla (meaning "glue") and gene. This etymology reflects the gelatinous, glue-like property of cooled bone broth that pre-modern cooks had observed long before the underlying biology was understood.
Collagen is mainly formed by the amino acid glycine (33%), proline and hydroxyproline (22%), arranged in a primary structure organized as a triple helix formed by three α-chains. Each alpha chain is composed of approximately 1,014 amino acids with a molecular weight of around 100 kDa. These chains are coiled into a left-handed helix with three amino acids per turn, then twisted around each other into a triple helix to form a rigid structure.
The primary amino acid sequence of collagen is glycine–proline–X or glycine–X–hydroxyproline, where X can be any of the other 17 amino acids, and every third amino acid is glycine. Collagen is composed of three chains wound together to form a triple helix. Because glycine is the smallest of all amino acids, it allows the chain to form a tight configuration that can withstand stress. Collagen contains two amino acids present in very few other proteins: hydroxyproline and hydroxylysine.
The lysine and proline residues receive additional hydroxyl groups via hydroxylase enzymes, which require vitamin C as a cofactor. Three of the hydroxylated and glycosylated pro-α-chains then assemble by twisting into a triple helix through zipper-like folding.
Collagen is categorized into 28 subtypes, with types I, II, and III making up 80–90% of the collagen in the human body. Collagen types are generally grouped by structural form: fibrillar (types I, II, III, V, and XI), which represent about 90% of all collagen protein found in mammals, and non-fibrillar types. The five most common types and their tissue distributions are: Type I: skin, tendon, organs, bone, vascular connective tissue; Type II: cartilage; Type III: reticular connective tissue, often associated with Type I collagen; Type IV: basement membranes of epithelial tissues; and Type V: hair, placenta, and external cellular membranes.
Types I, II, and III correspond to 80–90% of the total collagen found in the human body, and Type I is the most abundant in skin (80%). Type III collagen corresponds to approximately 15%. In cartilage, Type II collagen predominates, constituting 90–95% of the extracellular matrix.
The primary commercial sources of collagen used in supplements include bovine (cattle) hide and bone, porcine hide and bone, chicken sternal cartilage, and fish skin and scales. Bovine and porcine tissues are the major sources of collagen because of their wide availability and biocompatibility with human tissues.
Extraction of hydrolyzed collagen from traditional sources such as porcine and bovine involves certain limitations due to health concerns such as swine flu and bovine spongiform encephalopathy, as well as religious considerations. As a result, researchers have focused on developing new sources of extraction, including marine sources such as fish and other invertebrates including jellyfish and sponges.
Native collagen Type I can be extracted from different sources; however, the main source of extraction is bovine because of its availability and biocompatibility. Another common source is porcine by-products, which have high resemblance to human collagen.
Native collagen is a large and complex polymer with low solubility, absorbability, and bioavailability. To be used by the body, the large collagen polymer must first be broken down into smaller segments called peptides, a process accomplished by treatment with enzymes or acids called hydrolysis. All collagen supplements are more correctly called collagen peptides or hydrolyzed collagen.
Hydrolyzed collagen (HC) consists of many small and low-molecular-weight amino acid chains (3–6 kDa) that can be produced either in basic or acidic media through enzymatic activity. Hydrolyzed collagen was first industrially manufactured in the middle of the 20th century, initially used as a water binder in the meat industry and in the manufacturing of sports bars. In the early 1970s, collagen began to be used in dietary products as a substitute for sugar and fat.
The principal commercially available forms include:
Delivery formats include powders (the predominant form, soluble in hot or cold liquids), capsules, tablets, liquid preparations, and topical formulations. HC is widely used in several industries including food, pharmaceutical, cosmetic, biomedical, and leather industries.
The dietary tradition of bone broth predates the molecular characterization of collagen by centuries — by millennia in some traditions. Cooking with bone, simmering soup stocks, and using gelatinous preparations of connective tissue are practices the food-history literature has documented across essentially every region of the world.
This pervasiveness tells us something fundamental: broth was not a side dish but a survival technology, reinvented again and again across continents and centuries. Bones, skins, and blood — materials otherwise tough or perishable — were converted through time and patience into liquid strength, portable blocks, or concentrated extracts.
In Traditional Chinese Medicine, collagen-rich foods were used to support skin elasticity, healthy aging, and joint strength. Almost ten centuries ago, the Benedictine abbess and scholar Hildegard von Bingen was already studying extracts from animal tissue and had recognized their use as a remedy for joint complaints. In traditional Asian culture, collagen was used in cosmetics because of its perceived role in keeping skin young and tight and its general effect against skin aging.
In Europe, especially during the Middle Ages, collagen-rich foods were an integral part of traditional remedies. Hearty soups and stews made from animal bones, cartilage, and connective tissues were common in folk medicine. These preparations were believed to strengthen the body, ward off illness, and improve skin health during harsh winters.
Indigenous cultures around the world also utilized collagen-rich foods for generations. Native American tribes, for example, consumed boiled animal hides and bone marrow as a source of nutrients for strength and vitality. Similarly, traditional African medicine often involved using animal parts rich in gelatin to treat digestive issues and promote overall wellness.
Globally, diverse traditional cuisines independently developed collagen-rich preparations: In China, slow-cooked broths made with chicken feet or pork trotters were prized for their nourishing properties. French cuisine turned to pot-au-feu and aspics, relying on collagen-rich stock to set into delicate jellies. In Vietnam, the beloved soup pho gets its depth of flavor from beef bones simmered for hours. In Mexico, caldo de res makes full use of marrow bones and cartilage. In the Middle East, long-simmered lamb shank stews were valued as both comfort food and sustenance.
The molecular biology of the twentieth century simply explains, in chemical terms, what the bone broth tradition had been supplying all along — a particular protein family, with a distinctive amino acid profile, derived from connective tissue, in a form the body's own connective tissues can use as structural substrate. This framing positions modern collagen formulations within a continuous tradition. The convenience format — a powder that dissolves in a beverage rather than a broth that requires hours of simmering — is the contemporary contribution.
Collagen is mainly formed by the amino acid glycine (33%), proline and hydroxyproline (22%). The amino acid profile of bone broth, like that of all collagen-rich preparations, is dominated by the characteristic glycine–proline–hydroxyproline triad. Collagen is notably deficient in the essential amino acid tryptophan and is therefore considered an incomplete protein in the conventional nutritional sense.
Native collagen has a specific immune-mediated mechanism that requires the recognition of its epitopes to inhibit inflammation and tissue catabolism at the articular level. Hydrolyzed collagen may contain biologically active peptides that are able to reach joint tissues and exert chondroprotective effects.
According to this mechanism of action, native Type II collagen would reduce autoimmune reactions against endogenous collagen at the articular cartilage level.
Orally administered collagen in its many different forms is recognized as a highly biocompatible, safe form of supplementation, which has the potential to act on the body as an anti-inflammatory and antioxidant, and through structural remodeling and reduced lipotoxicity.
Collagen peptide supplementation (COL), in conjunction with exercise, may be beneficial for the management of degenerative bone and joint disorders. This is likely due to stimulatory effects of COL and exercise on the extracellular matrix of connective tissues, improving structure and load-bearing capabilities.
One systematic review analyzed 10 randomized clinical trials and concluded that the consumption of both intact and hydrolyzed collagen improves clinical manifestations of skin health by either increasing the synthesis of extracellular matrix or the interaction of regulatory T-cells and Type 2 macrophages in maintaining the skin immune response to endogenous collagen.
Emerging data suggest that hydrolyzed collagen peptides may improve skin elasticity, joint function, and recovery after exercise, particularly when co-supplemented with vitamin C, silica, or resveratrol. The requirement for vitamin C as a cofactor in the hydroxylation of lysine and proline residues during collagen synthesis is an established biochemical mechanism linking ascorbic acid status to collagen production.
Skin aging is accompanied by declining collagen content. Skin aging is characterized by a decrease in the levels of collagen, elastin fiber, and hyaluronic acid, resulting in a loss of skin elasticity and hydration. Prior studies suggest that oral collagen supplements can help increase collagen, elastin, and hyaluronic acid levels, ultimately improving skin health.
Evidence strength: Moderate to moderately strong from multiple RCTs and several systematic reviews and meta-analyses.
A systematic review and meta-analysis published on PubMed, utilizing data from 10 RCTs with a total of 646 participants, found that collagen supplements were statistically effective in increasing skin hydration (SMD 1.25; 95% CI: 0.77–1.74) and elasticity (SMD 0.61; 95% CI: 0.21–1.02).
All human studies included in one review were randomized controlled trials mainly conducted in high- to middle-income countries, which highlighted that both oral and topical collagen supplements help to delay the aging process, with no differences arising between the two types of collagen.
Literature data have shown that hydrolyzed collagen supplementation promotes skin changes including decreased wrinkle formation, increased skin elasticity, increased hydration, increased collagen content, density, and synthesis — factors closely associated with aging-related skin damage.
A systematic review published in the Journal of Drugs in Dermatology (2019), encompassing RCTs only, concluded that preliminary results are promising for the short- and long-term use of oral collagen supplements for wound healing and skin aging. Oral collagen supplements also increase skin elasticity, hydration, and dermal collagen density. Collagen supplementation is generally safe with no reported adverse events. Further studies are needed to elucidate medical use in skin barrier diseases and to determine optimal dosing regimens.
Limitations: While in vitro and small-scale clinical studies offer promising results, robust evidence from large randomized controlled trials remains limited. Many trials have been industry-funded, study durations are often short (4–12 weeks), and placebo-blinding can be challenging with collagen powders.
Evidence strength: Moderate, supported by multiple RCTs and several meta-analyses, though heterogeneity across studies limits overall certainty.
A systematic review and meta-analysis (PMC, 2023) conducting a comprehensive search across PubMed, Scopus, EMBASE, Web of Science, Cochrane, and ClinicalTrials.gov concluded that a systematic review and meta-analysis provides compelling evidence of significant pain reduction in knee osteoarthritis patients who received collagen peptides compared to those who received a placebo.
However, earlier meta-analyses have identified methodological challenges. The low number of studies in one meta-analysis resulted in generally low certainty of evidence. In the meta-analysis by GarcĂa-Coronado et al., only 5 trials were included; although a significant decrease in the WOMAC index following collagen derivative administration was identified, the high heterogeneity hindered the generalizability of the results.
For exercise-related joint pain in athletes, a systematic review of 15 RCTs found that collagen supplementation increased pain-free time to exertion and collagen synthesis; 5–15 g/day doses of COL, when taken at least 1 hour prior to exercise for over 3 months, may aid in reducing functional joint pain and improving muscle recovery. The beneficial effects of COL appear to take effect after three months or longer.
One systematic review concluded that collagen supplementation is strongly indicated for its positive therapeutic effect on pain management of osteoarthritis.
Evidence strength: Preliminary, with a small number of RCTs predominantly in postmenopausal women.
Literature data indicate that collagen supplementation increases bone strength, density, and mass; improves joint stiffness and mobility; and improves functionality. These findings principally derive from studies in postmenopausal women with osteopenia. One RCT referenced in the literature assessed the effect of calcium and vitamin D supplementation with and without collagen peptides on bone turnover in postmenopausal women with osteopenia. A calcium-collagen chelate dietary supplement has also been studied for attenuation of bone loss in postmenopausal women with osteopenia. These findings are promising but require larger, independent replications.
Evidence strength: Preliminary to moderate; results are promising but dependent on co-intervention with exercise.
Collagen peptide supplementation in conjunction with exercise may be beneficial for the management of degenerative bone and joint disorders. A randomized, double-blind, crossover clinical trial published in 2023 investigated dietary collagen peptides for post-exercise muscle soreness and fatigue, which can negatively affect exercise performance. It is desirable to attenuate muscle soreness and fatigue and promote recovery.
Study populations in the systematic review on collagen and exercise included 12 studies in recreational athletes, 2 studies in elderly participants, and 1 in untrained pre-menopausal women. The overall finding was that collagen peptide supplementation combined with exercise showed benefits for joint pain and collagen synthesis. However, other higher quality protein sources, such as whey protein, may be more beneficial for muscle protein synthesis.
Evidence strength: Moderate for topical collagen dressings in chronic wounds; preliminary for oral supplementation.
A meta-analysis of 11 RCTs (PMC, 2022) on collagen dressings for chronic wounds found that in 11 studies with a total of 961 patients, the collagen group achieved a higher wound healing rate compared with standard of care alone (Risk Ratio = 1.53; 95% CI, 1.33–1.77) and a higher healing velocity (Mean Difference, 2.69; 95% CI, 0.87–4.51).
For oral supplementation, collagen oral administration has been described as an efficient treatment for wound healing, and collagen could be an important nutritional supplement for those who suffered from fractures and contusions caused by accidents. A randomized, double-blind pilot clinical trial published in Burns (2020) investigated the effect of a hydrolyzed collagen-based supplement on wound healing in patients with burns.
Promising results were also seen for the use of collagen supplementation in osteoporosis, hypertension, rheumatoid arthritis, tendinopathy, cellulite, and atopic dermatitis. In clinical studies, collagen treatments have been reviewed for applications including skin regeneration, bone defects, sarcopenia, wound healing, dental therapy, gastroesophageal reflux, osteoarthritis, and rheumatoid arthritis. The evidence for most of these additional areas remains at the preliminary or investigational stage.
A pilot clinical study published in Nutrients (2019) examined the effects of collagen hydrolysates on human brain structure and cognitive function, representing an emerging direction that lacks sufficient evidence for conclusions to be drawn.
Dosages across clinical studies vary widely depending on the indication, collagen type, and formulation. The following reflect dosages as reported in peer-reviewed sources:
The use of nutraceuticals such as collagen for skincare has been rising, but regulations are lacking on quality, absorption, and efficacy. To address this knowledge gap, clinical studies regarding the potential effects of collagen-based dietary supplements on skin are being completed. Optimal dosing regimens across indications have not yet been definitively established by the available clinical literature.
Prolonged use of collagen is deemed to be safe, with none of the studies within one systematic review reporting any adverse effects of collagen supplementation, even at higher doses (60 g/day) or in different supplement forms. Collagen supplementation is generally safe with no reported adverse events across the RCTs surveyed in multiple systematic reviews.
Some collagen supplements are sourced from animals — particularly marine and bovine sources. Individuals with allergies to seafood or specific animals could be at risk of allergic reactions or sensitivities when consuming collagen derived from these sources. One of the main concerns about consuming marine collagen is the risk of allergies. People who are allergic to fish may develop allergic reactions when consuming this type of collagen. Symptoms may include itching, rashes, swelling, or even difficulty breathing.
A notable, source-documented safety concern relates to potential contamination. A prominent study evaluating popular collagen supplement brands in the US found that 64% tested positive for measurable levels of arsenic, 37% for lead, 34% for trace levels of mercury, and 17% for measurable levels of cadmium. In some cases, detected levels of heavy metals exceeded regulatory thresholds, with certain elements measuring two to three times the permissible limits. The presence of these contaminants poses serious health threats, highlighting the need for enhanced quality control and regulatory supervision.
However, a peer-reviewed 2025 PubMed study analyzing marine collagen supplements (fish and jellyfish derived) found that significant variability was observed between brands. Mercury was detectable in only 12% of the samples. Marine collagen samples derived from jellyfish and Scomber scombrus skin extract showed no detectable toxic metals. None of the samples exceeded EU regulatory limits, and average daily doses were consistently below tolerable daily intakes, indicating safety for consumption at recommended doses. However, it is recommended that food safety regulations be updated to account for potential cumulative risks from simultaneous intake of contaminated supplements.
HC extraction from traditional sources such as porcine and bovine involves limitations due to health concerns such as swine flu and bovine spongiform encephalopathy. Religious issues must also be included as considerations. These concerns have driven the development of alternative marine and plant-adjacent collagen-inducing formulations.
Collagen is an incomplete protein, as it lacks the essential amino acid tryptophan. It should not be used as a sole protein source. Its amino acid profile is distinct from complete dietary proteins (e.g., whey, eggs), and for muscle protein synthesis specifically, other higher quality protein sources, such as whey protein, may be more beneficial for muscle protein synthesis.
The FDA classifies hydrolyzed collagen as "Generally Recognized as Safe" (GRAS), meaning it has a long history of safe use in food products. Collagen is regulated as a dietary supplement in the United States and as a food ingredient in many other jurisdictions. It is not approved as a drug for any indication.
With increasing consumer and clinical interest, collagen supplementation has expanded rapidly, yet scientific evidence supporting its efficacy in anti-aging and regenerative applications remains inconsistent. Current evidence has been evaluated in over 60 clinical studies assessing its effects on skin aging, musculoskeletal health, and hair disorders.
Health conditions that Collagen may help support.
Undenatured type II collagen (UC-II) and hydrolyzed collagen peptides have been evaluated in multiple RCTs for osteoarthritis and rheumatoid arthritis. A 2016 multicenter double-blind RCT found UC-II significantly outperformed glucosamine+chondroitin on WOMAC pain, stiffness, and function. The 2017 dietary supplements meta-analysis (69 RCTs) identified collagen hydrolysate as showing a large clinical effect size for OA pain.
Collagen peptide (CP) supplementation combined with exercise shows strong evidence for improving tendon structural outcomes relevant to athletic performance, including increased tendon cross-sectional area and stiffness. A 24-week RCT in 147 collegiate athletes found 10 g/day collagen hydrolysate significantly reduced activity-related joint pain versus placebo. However, a 2024 meta-analysis of 13 RCTs found no significant effect of CP on strength-related performance outcomes, indicating benefits are primarily connective-tissue and pain-related rather than muscle-performance-related.
Spinal intervertebral discs are composed primarily of type I and type II collagen, and degenerative disc disease involves progressive collagen breakdown in the annulus fibrosus and nucleus pulposus. A randomized, double-blind, placebo-controlled trial found collagen peptide ingestion significantly improved functional limitations associated with lower back discomfort. Evidence is early-stage but mechanistically plausible and supported by at least one RCT.
Collagen (type I) constitutes approximately 90% of the organic bone matrix and provides the scaffold for mineral deposition. A 2018 double-blind RCT in 131 postmenopausal women found that 5 g/day specific collagen peptides for 12 months significantly increased BMD at the femoral neck and spine versus placebo, with elevated bone formation markers. A 2025 meta-analysis of four RCTs confirmed this benefit.
Collagen supplementation (particularly type II/undenatured) supports joint cartilage structure and reduces inflammation in arthritic joints. Podiatric specialists cite collagen peptides as among the best-evidenced supplements for reducing big toe joint inflammation and pain. Type II collagen is the structural protein in articular cartilage lining joints like the first metatarsophalangeal joint affected by bunions.
Collagen dressings and oral hydrolyzed collagen supplementation have clinical evidence for benefit in burn wound healing. A randomized double-blind pilot RCT in 31 burn patients (20–30% TBSA) found oral collagen supplementation significantly raised pre-albumin levels and accelerated wound healing. Collagen sheet dressings are documented as useful in first- and second-degree burns, reducing pain from dressing changes and supporting epithelialization.
Collagen is the primary structural protein of articular cartilage. Both hydrolyzed collagen and undenatured type II collagen have been studied in clinical trials for OA. Hydrolyzed collagen is absorbed and incorporated into joint cartilage with clinical evidence of improved mobility and pain. Undenatured type II collagen induces oral tolerance via gut-associated lymphoid tissue, reducing autoimmune-like cartilage degradation. Multiple systematic reviews support its role in cartilage repair.
Oral bioactive collagen peptides (BCP, 2.5 g/day) showed statistically significant improvement in cellulite in a double-blind, placebo-controlled RCT of 105 women over 6 months, with improved dermal density and reduced skin waviness on thighs. Multiple systematic reviews confirm promising evidence for oral collagen in cellulite.
Collagen type I is the predominant organic matrix protein of bone (~30% by dry weight) and provides the structural scaffold upon which hydroxyapatite mineralizes. Its integrity is essential for bone toughness and mechanical strength. Collagen-derived ingredients such as MCHC provide native collagen alongside bone minerals in supplemental form.
Collagen peptides have demonstrated anti-inflammatory activity by inhibiting secretion of pro-inflammatory cytokines (IL-6, TNF-α, NF-κB pathway) in cell and animal models, and immunomodulatory effects have been observed in clinical contexts including osteoarthritis and a COVID-19 RCT. Evidence is strongest at the preclinical level but is supported by clinical inference from OA and joint trials. The detailed mechanism of collagen-induced immunomodulation in humans remains elusive.
Hydrolyzed collagen (collagen peptides) supplementation reduces chronic joint pain in osteoarthritis and activity-related joint pain. RCTs show significant reductions in OA knee pain and improved function. Collagen peptides stimulate chondrocyte collagen synthesis and are recognized as a joint health supplement for chronic musculoskeletal pain.
Collagen is the most abundant structural protein in connective tissues including skin, cartilage, tendons, ligaments, and bone. Multiple clinical trials and a systematic review of 41 animal and human studies found that collagen supplementation benefits osteoarthritis and aids cartilage repair. Hydrolyzed collagen peptides have been shown to improve skin elasticity, joint function, and musculoskeletal tissue remodeling.
Collagen loss in the thin periorbital skin exposes underlying vasculature and creates shadowing that manifests as dark circles; topical collagen peptides and collagen-stimulating formulations are used to thicken this skin. Peptides that stimulate collagen synthesis have shown 20–35% improvement in vascular-type dark circles in clinical assessments. Retinoids are validated collagen-synthesis stimulators also used for periorbital dark circles.
Oral hydrolyzed collagen peptides improve skin hydration in multiple randomized double-blind placebo-controlled trials and meta-analyses. Collagen peptides stimulate dermal fibroblast synthesis of new collagen, elastin, and hyaluronic acid, reducing TEWL and improving dry skin. A 12-week RCT (n=64, 1000 mg/day) showed significantly higher skin hydration values versus placebo at 6 and 12 weeks.
Hydrolyzed collagen peptides and undenatured type II collagen have been studied in RCTs for osteoarthritis and joint pain. A meta-analysis of RCTs (PMC10505327) confirmed significant pain reduction in knee OA patients vs. placebo. A 2025 RCT of hydrolyzed collagen peptides showed significant WOMAC improvements at weeks 1, 4, and 8. A 2025 network meta-analysis of 4,599 KOA patients also ranked collagen among supplements with meaningful benefit.
Type II collagen, the principal structural protein of the vitreous humor, was included in the 2025 pilot RCT combination supplement (n=40 eyes) for post-Nd:YAG floaters, where the treatment group showed significant improvements in floater perception and contrast sensitivity. It is proposed to provide substrate for vitreous fibrillary matrix repair alongside vitamin C and glycosaminoglycans.
Bioactive collagen peptides supplemented orally have been evaluated in a double-blind RCT in chronic periodontitis aftercare patients, with the collagen group showing significantly decreased bleeding on probing sites and lower periodontal inflamed surface area scores vs. placebo at 90 days. Collagen peptides are the primary structural protein of the periodontium and their supplementation supports connective tissue repair in treated periodontitis.
Oral collagen peptides provide amino acid substrates (notably proline, glycine, and hydroxyproline) that support keratin synthesis and dermal matrix integrity around follicles. A 2023 randomized controlled trial using marine hydrolyzed collagen combined with amino acids, iron, and selenium improved clinical outcomes in AGA and telogen effluvium patients. A 2022 study found fish-derived collagen peptides promoted human dermal papilla cell proliferation and stimulated hair regrowth in mice.
Collagen peptides provide amino acids—particularly proline, glycine, and hydroxyproline—that support the dermal matrix surrounding hair follicles. A systematic review found collagen peptides improve the clinical appearance, strength, and brittleness of hair. Collagen also constitutes the connective tissue sheath anchoring follicles, and its degradation with aging is associated with follicle miniaturization.
Collagen is the most abundant structural protein in the body; endogenous production declines with age, contributing to skin wrinkling, joint deterioration, and bone loss. Multiple randomized controlled trials demonstrate that oral hydrolyzed collagen peptides (2.5–15 g/day) improve skin elasticity, reduce wrinkles, support joint comfort, and increase bone density in older adults.
Collagen peptide supplementation is supported by multiple systematic reviews and RCTs for reducing joint and muscle pain in active individuals, improving recovery-related biomechanical characteristics after EIMD, and supporting connective tissue repair during exercise. Benefits for myofibrillar protein synthesis are lower than for whey protein.
Multiple RCTs indicate that collagen peptide supplementation reduces exercise-induced muscle soreness and accelerates recovery markers. A 2023 randomized double-blind crossover trial in middle-aged males found 10 g/day of collagen peptides for 33 days significantly alleviated post-exercise muscle soreness versus placebo. A 12-week RCT combining collagen peptides with concurrent training also showed significantly improved recovery-related biomechanical markers after eccentric muscle damage.
A 2017 open-label trial published in the Journal of Cosmetic Dermatology (PMID 28786550) found that 2.5 g/day of specific bioactive collagen peptides for 24 weeks increased nail growth rate by 12% and reduced the frequency of broken nails by 42% in 25 women with brittle nail syndrome. Collagen peptides supply glycine and proline used in keratin synthesis and nail matrix support.
Collagen constitutes approximately 90% of bone's protein matrix, providing the flexible scaffold for mineral deposition. Specific collagen peptides (SCP) supplementation at 5 g/day improved BMD of the spine and femoral neck significantly in a placebo-controlled RCT of 131 postmenopausal women. A PMC review confirmed collagen peptides show a positive effect on bone strength and mineral density, with evidence of increased bone formation markers.
Collagen supplementation has been studied for physical endurance and stamina via its role in supporting connective tissue integrity (tendons, ligaments, cartilage) that underlies sustained physical activity. Specific hydrolyzed collagen formulations combined with vitamin C have been shown in RCTs to enhance collagen synthesis in tendons and support injury prevention and recovery in endurance athletes.
Collagen peptides supply glycine, proline, and hydroxyproline—key building blocks for post-surgical tissue repair. Clinical and animal studies confirm collagen peptide supplementation enhances wound healing, connective tissue regeneration, fibroblast proliferation, and extracellular matrix biosynthesis. Orthopedic narrative reviews highlight collagen peptides as emerging evidence-based support for post-surgical recovery.
Collagen provides structural support for postpartum tissue repair, including healing of perineal lacerations, uterine involution, and recovery of pelvic floor musculature. Expert postnatal formulas recommend collagen peptides postpartum for wound healing, skin recovery, and hair regrowth. A US patent for postpartum recovery specifically cites collagen peptides alongside zinc for pelvic floor restoration.
Oral type II collagen (undenatured) induces immune tolerance to cartilage antigens in RA via gut-associated lymphoid tissue, reducing autoimmune attacks on joints. A clinical study in RA patients found type II collagen at low doses (0.1–0.5 mg/day) produced substantial joint improvement including reduction in swollen joints, and ConsumerLab lists collagen hydrolysate among RA supplements under study.
Collagen is the primary structural protein of scar tissue and has been studied extensively as a topical and supplemental agent for wound healing and scar modulation. Clinical trials show hydrolyzed collagen peptides accelerate tissue repair, and collagen dressings improve wound quality and scar outcomes.
Abnormal collagen composition and distribution in paraspinal muscles has been directly implicated as a contributing factor in idiopathic scoliosis curve initiation and progression. Studies of scoliotic rats demonstrate that TGF-β1–mediated collagen hyperplasia in paraspinal muscles generates asymmetric spinal tension, promoting curvature. Collagen supplementation is used to support spinal connective tissue integrity in scoliosis management.
Oral hydrolyzed collagen peptides have been evaluated in multiple randomized, double-blind, placebo-controlled trials. Several RCTs demonstrate improvements in wrinkle depth, skin elasticity, and hydration within 8–12 weeks. A 2025 systematic review notes that industry-independent high-quality trials show more modest effects, but a general pattern of efficacy for hydrolyzed collagen in skin aging is supported by the literature.
Oral hydrolyzed collagen is among the most extensively studied supplements for skin elasticity and collagen density. Multiple meta-analyses of RCTs (up to 26 RCTs, 1721 participants) demonstrate significant improvements in skin elasticity and hydration after 8–12 weeks at doses of 1–10 g/day. Fibroblasts recognize bioactive peptides (e.g., Pro-Hyp, Gly-Pro-Hyp) and upregulate collagen and hyaluronic acid synthesis.
Ligaments and tendons—the structures damaged in sprains—are composed predominantly of type I collagen. A 2026 systematic review found GRADE A evidence that collagen supplementation combined with loaded training increases tendon cross-sectional area and stiffness. The systematic review on type I collagen hydrolysate (36 RCTs) also reported improved ankle function as a beneficial outcome, directly relevant to sprain recovery and prevention.
Collagen type I provides the organic scaffold upon which mineral crystals nucleate and grow during dentin remineralization. Preservation of intact collagen fibrils in demineralized dentin is essential for intrafibrillar and extrafibrillar mineral redeposition. Agents that protect collagen (such as EGCG or crosslinkers) improve remineralization outcomes; collagen-based materials are also investigated as direct scaffolds for biomimetic remineralization.
Collagen is both a fundamental structural component of wound healing and a clinically used biomaterial scaffold for wound management. Oral and topical collagen supplementation supports wound healing by providing essential amino acids and acting as a structural template for tissue regeneration. Multiple RCTs support oral collagen for wound outcomes.
Collagen supplementation—particularly in the form of hydrolyzed collagen peptides—has been used traditionally (particularly as bone broth) for gut lining support and is increasingly studied for intestinal barrier support. Collagen provides glycine, proline, and hydroxyproline—amino acids critical for intestinal epithelial cell integrity and repair. Traditional use spans multiple cultures as a gut-healing food (bone broth), and modern functional medicine promotes it for leaky gut.
Body systems that Collagen may help support.
Go back